Hirtle Callaghan & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$135M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$56.5M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$23.8M |
| 4 |
Vanguard Value ETF
VTV
|
+$14.2M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$19.9M |
| 2 |
Apple
AAPL
|
+$16.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12.7M |
| 4 |
Microsoft
MSFT
|
+$12.6M |
| 5 |
TSMC
TSM
|
+$9.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 1.03% |
| 2 | Communication Services | 0.9% |
| 3 | Financials | 0.63% |
| 4 | Technology | 0.22% |
| 5 | Healthcare | 0.13% |
Similar funds
Hirtle Callaghan & Co's Q1 2025 Portfolio in Review
As of Q1 2025, Hirtle Callaghan & Co held 127 positions worth $2.57B, up 8.1% from $2.38B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Hirtle Callaghan & Co deployed $161M of net new capital in Q1 2025, opening 8 new positions and adding to 22 existing holdings. Its largest new stake was Novo Nordisk: 18,561 shares worth $1.29M.
By sector, the portfolio is most concentrated in Consumer Staples at 1% of assets, down from 1.1% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $19.9M trimmed.
- Hirtle Callaghan & Co's largest Q1 2025 buy was Novo Nordisk: 18,561 shares worth $1.29M.
- Hirtle Callaghan & Co added most to Vanguard S&P 500 ETF in Q1 2025, an estimated $135M increase.
- Hirtle Callaghan & Co's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $19.9M.
- Hirtle Callaghan & Co fully exited iShares MSCI USA Min Vol Factor ETF in Q1 2025, selling an estimated $2.32M.
- Hirtle Callaghan & Co's ten largest holdings make up 76% of its $2.57B portfolio in Q1 2025.
- Hirtle Callaghan & Co opened 8 new positions and closed 20 in Q1 2025.
- Hirtle Callaghan & Co's portfolio value rose 8.1% quarter-over-quarter to $2.57B.
Based on Hirtle Callaghan & Co's 13F filing for Q1 2025, filed 12 May 2025.